TrialCancer2017

Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study.

Eytan Ben-Ami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.